135 related articles for article (PubMed ID: 21852811)
1. Influence of osteopontin expression on the metastatic growth of CC531 rat colorectal carcinoma cells in rat liver.
Uhlmann ME; Georges RB; Boleij A; Eyol E; Kubarenko A; Adwan H; Berger MR
Cancer Gene Ther; 2011 Nov; 18(11):795-805. PubMed ID: 21852811
[TBL] [Abstract][Full Text] [Related]
2. Regulation of osteopontin and related proteins in rat CC531 colorectal cancer cells.
Georges R; Adwan H; Zhivkova M; Eyol E; Bergmann F; Berger MR
Int J Oncol; 2010 Aug; 37(2):249-56. PubMed ID: 20596651
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.
Chen RX; Xia YH; Xue TC; Zhang H; Ye SL
Oncol Rep; 2011 Mar; 25(3):803-8. PubMed ID: 21174062
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of osteopontin and bone sialoprotein II is related to reduced colony formation and metastasis formation of MDA-MB-231 human breast cancer cells.
Adwan H; Bäuerle TJ; Berger MR
Cancer Gene Ther; 2004 Feb; 11(2):109-20. PubMed ID: 14647232
[TBL] [Abstract][Full Text] [Related]
5. Interferon-induced transmembrane 3 binds osteopontin in vitro: expressed in vivo IFITM3 reduced OPN expression.
El-Tanani MK; Jin D; Campbell FC; Johnston PG
Oncogene; 2010 Feb; 29(5):752-62. PubMed ID: 19901966
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
Wai PY; Mi Z; Guo H; Sarraf-Yazdi S; Gao C; Wei J; Marroquin CE; Clary B; Kuo PC
Carcinogenesis; 2005 Apr; 26(4):741-51. PubMed ID: 15661802
[TBL] [Abstract][Full Text] [Related]
7. EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells.
Zhang J; Guo H; Mi Z; Gao C; Bhattacharya S; Li J; Kuo PC
Exp Cell Res; 2009 Jan; 315(2):304-12. PubMed ID: 19026636
[TBL] [Abstract][Full Text] [Related]
8. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
Mi Z; Guo H; Wai PY; Gao C; Kuo PC
Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
[TBL] [Abstract][Full Text] [Related]
9. [Expression of osteopontin mRNA and its protein in colorectal cancer and liver metastatic tissues].
Ding L; Zheng S; Cao J
Zhonghua Yi Xue Za Zhi; 2002 Jul; 82(14):970-3. PubMed ID: 12181091
[TBL] [Abstract][Full Text] [Related]
10. Suppression of colorectal cancer liver metastasis and extension of survival by expression of apolipoprotein(a) kringles.
Yu HK; Kim JS; Lee HJ; Ahn JH; Lee SK; Hong SW; Yoon Y
Cancer Res; 2004 Oct; 64(19):7092-8. PubMed ID: 15466205
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin gene expression determines spontaneous metastatic performance of orthotopic human breast cancer xenografts.
Suzuki M; Mose E; Galloy C; Tarin D
Am J Pathol; 2007 Aug; 171(2):682-92. PubMed ID: 17620367
[TBL] [Abstract][Full Text] [Related]
12. [Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].
Lin F; Li YY; Xia JT; Wen MJ; Lai YY; Cai WS; Wu ZF; Fan SF
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):422-5. PubMed ID: 19567019
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis.
Khatib AM; Fallavollita L; Wancewicz EV; Monia BP; Brodt P
Cancer Res; 2002 Oct; 62(19):5393-8. PubMed ID: 12359742
[TBL] [Abstract][Full Text] [Related]
14. A small interfering RNA targeting osteopontin as gastric cancer therapeutics.
Gong M; Lu Z; Fang G; Bi J; Xue X
Cancer Lett; 2008 Dec; 272(1):148-59. PubMed ID: 18694621
[TBL] [Abstract][Full Text] [Related]
15. Lentiviral-mediated siRNA targeted against osteopontin suppresses the growth and metastasis of gastric cancer cells.
Wang ZM; Cui YH; Li W; Chen SY; Liu TS
Oncol Rep; 2011 Apr; 25(4):997-1003. PubMed ID: 21286666
[TBL] [Abstract][Full Text] [Related]
16. [Expression and clinical significance of osteopontin in colorectal cancer and liver metastatic tissues].
Ding L; Zheng S
Zhonghua Wai Ke Za Zhi; 2002 Oct; 40(10):773-5. PubMed ID: 12487883
[TBL] [Abstract][Full Text] [Related]
17. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
Liu H; Chen A; Guo F; Yuan L
Cancer Lett; 2010 Sep; 295(1):27-37. PubMed ID: 20207476
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis.
Zhao J; Dong L; Lu B; Wu G; Xu D; Chen J; Li K; Tong X; Dai J; Yao S; Wu M; Guo Y
Gastroenterology; 2008 Sep; 135(3):956-68. PubMed ID: 18555021
[TBL] [Abstract][Full Text] [Related]
19. Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1.
Metge BJ; Liu S; Riker AI; Fodstad O; Samant RS; Shevde LA
Oncology; 2010; 78(1):75-86. PubMed ID: 20215788
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin is involved in the formation of malignant pleural effusion in lung cancer.
Cui R; Takahashi F; Ohashi R; Yoshioka M; Gu T; Tajima K; Unnoura T; Iwakami S; Hirama M; Ishiwata T; Iwase A; Takahashi K
Lung Cancer; 2009 Mar; 63(3):368-74. PubMed ID: 18752867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
